全文获取类型
收费全文 | 72986篇 |
免费 | 6713篇 |
国内免费 | 2633篇 |
专业分类
耳鼻咽喉 | 805篇 |
儿科学 | 1555篇 |
妇产科学 | 3996篇 |
基础医学 | 7040篇 |
口腔科学 | 1232篇 |
临床医学 | 6825篇 |
内科学 | 6001篇 |
皮肤病学 | 975篇 |
神经病学 | 2311篇 |
特种医学 | 3738篇 |
外国民族医学 | 52篇 |
外科学 | 9418篇 |
综合类 | 12394篇 |
现状与发展 | 19篇 |
预防医学 | 2427篇 |
眼科学 | 643篇 |
药学 | 5027篇 |
54篇 | |
中国医学 | 2126篇 |
肿瘤学 | 15694篇 |
出版年
2024年 | 67篇 |
2023年 | 1024篇 |
2022年 | 1658篇 |
2021年 | 2930篇 |
2020年 | 2513篇 |
2019年 | 2325篇 |
2018年 | 2168篇 |
2017年 | 2511篇 |
2016年 | 2785篇 |
2015年 | 2933篇 |
2014年 | 4758篇 |
2013年 | 4637篇 |
2012年 | 4358篇 |
2011年 | 4769篇 |
2010年 | 3794篇 |
2009年 | 3810篇 |
2008年 | 3760篇 |
2007年 | 4024篇 |
2006年 | 3643篇 |
2005年 | 3249篇 |
2004年 | 2811篇 |
2003年 | 2347篇 |
2002年 | 2110篇 |
2001年 | 1925篇 |
2000年 | 1554篇 |
1999年 | 1354篇 |
1998年 | 1106篇 |
1997年 | 972篇 |
1996年 | 818篇 |
1995年 | 861篇 |
1994年 | 732篇 |
1993年 | 556篇 |
1992年 | 467篇 |
1991年 | 377篇 |
1990年 | 305篇 |
1989年 | 293篇 |
1988年 | 281篇 |
1987年 | 249篇 |
1986年 | 187篇 |
1985年 | 237篇 |
1984年 | 207篇 |
1983年 | 140篇 |
1982年 | 176篇 |
1981年 | 153篇 |
1980年 | 101篇 |
1979年 | 93篇 |
1978年 | 68篇 |
1977年 | 46篇 |
1976年 | 43篇 |
1975年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
5.
6.
7.
8.
目的 观察超声引导下关节腔内注射重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白(益赛普)治疗血友病性关节病(HA)的价值。方法 回顾性分析32例接受超声引导下穿刺关节腔注射益赛普的HA患者,对比观察治疗前及治疗后1个月血友病关节健康评分(HJHS)、视觉模拟评分(VAS),以及超声所示目标关节增生滑膜厚度、血流信号、Melchiorre及中国早期血友病性关节病超声检测(HEAD-US-C)评分,评估其治疗价值。结果 对32例均成功完成超声引导下穿刺关节腔及腔内注射益赛普,共对18例膝关节、7例肘关节及7例踝关节进行治疗。术后未出现感染、出血等并发症。治疗后1个月,目标关节HJHS、VAS、Melchiorre评分、HEAD-US-C评分及增生滑膜最大厚度、平均厚度、血流信号均低于治疗前(P均<0.01)。结论 超声引导下关节腔内注射益赛普治疗HA安全、有效。 相似文献
9.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
10.